about
Taenia solium cysticercosisBuilding a platform for translational research in chronic noncommunicable diseases to address population health: lessons from NHLBI supported CRONICAS in PeruEvans blue staining reveals vascular leakage associated with focal areas of host-parasite interaction in brains of pigs infected with Taenia soliumCharacterization of a novel Taenia solium oncosphere antigen.Nested PCR for specific diagnosis of Taenia solium taeniasis.Imaging findings in neurocysticercosis.Species identification after treatment for human taeniasis.A novel Taenia solium protein that resembles troponin T proteins.Taenia solium cysticercosis hotspots surrounding tapeworm carriers: clustering on human seroprevalence but not on seizures.Zoonotic larval cestode infections: neglected, neglected tropical diseases?The effect on cardiovascular risk factors of migration from rural to urban areas in Peru: PERU MIGRANT Study.Development of a species-specific coproantigen ELISA for human Taenia solium taeniasis.Epilepsy and neurocysticercosis: an incidence study in a Peruvian rural population.Detection of Taenia solium antigens and anti-T. solium antibodies in paired serum and cerebrospinal fluid samples from patients with intraparenchymal or extraparenchymal neurocysticercosisDevelopment and evaluation of a magnetic immunochromatographic test to detect Taenia solium, which causes taeniasis and neurocysticercosis in humans.TsAg5, a Taenia solium cysticercus protein with a marginal trypsin-like activity in the diagnosis of human neurocysticercosis.Tuberculin skin-test reactions are unaffected by the severity of hyperendemic intestinal helminth infections and co-infections.Cognitive changes and quality of life in neurocysticercosis: a longitudinal studyEfficacy of combined antiparasitic therapy with praziquantel and albendazole for neurocysticercosis: a double-blind, randomised controlled trial.Ring-screening to control endemic transmission of Taenia solium.Enhanced steroid dosing reduces seizures during antiparasitic treatment for cysticercosis and early afterHuman and canine echinococcosis infection in informal, unlicensed abattoirs in Lima, PeruImproved serodiagnosis of cystic echinococcosis using the new recombinant 2B2t antigen.Seroprevalence and risk factors for Taenia solium cysticercosis in rural pigs of northern PeruNew insights in cysticercosis transmission.Taenia solium Cysticercosis--The lessons of history.Geographic correlation between tapeworm carriers and heavily infected cysticercotic pigs.Hymenolepis nana infection: symptoms and response to nitazoxanide in field conditions.Mechanisms regulating monocyte CXCL8 secretion in neurocysticercosis and the effect of antiparasitic therapy.Taenia solium infection in Peru: a collaboration between Peace Corps Volunteers and researchers in a community based study.Neurocysticercosis-more than a neglected disease.Serologic diagnosis of human Taenia solium cysticercosis by using recombinant and synthetic antigens in QuickELISA™.Relationship between serum antibodies and Taenia solium larvae burden in pigs raised in field conditions.Epilepsy and neurocysticercosis in Latin America: a systematic review and meta-analysis.Neurocysticercosis as a cause of epilepsy and seizures in two community-based studies in a cysticercosis-endemic region in Peru.Neurocysticercosis: A natural human model of epileptogenesis.Pharmacokinetics of combined treatment with praziquantel and albendazole in neurocysticercosis.Calcified neurocysticercosis associates with hippocampal atrophy: a population-based study.Seizures, cysticercosis and rural-to-urban migration: the PERU MIGRANT study.Diagnosis, treatment and control of Taenia solium cysticercosis.
P50
Q24630431-20AA017A-F6D8-49D6-BD22-550D03226321Q26827283-CD8A2668-14E8-475A-83E1-A6003A3AB8E1Q28539528-7529E74F-2DBF-4243-8012-E6EE2C5D26F0Q30364569-A1601A53-9653-4738-8B3E-C720BD279800Q30442548-4835D9EB-DACB-4E6D-8ECB-D22A751CC9F2Q30799563-AEA2608D-2AC2-44CC-B482-C0FCEB3C557AQ33200197-A9FF0F75-2B0E-429D-B808-934CE91E7D79Q33393812-96B69D50-18BC-4F76-B880-9C22FBB737E7Q33403182-E42A166A-C979-40F2-B5BD-B868837950D7Q33411742-7C2BDF70-8450-416C-A7BF-3B1F79CF6B54Q33463873-01C07D99-C90D-43E2-B678-8023ADD2B8BAQ33496662-440E4B25-6BDE-4B0F-A848-E775C67E8DCDQ33678330-46F74BC4-CEEF-4170-A9D2-E3E3D78D716FQ33763145-1EFFFE02-1E84-4922-A733-7B9A188100A0Q33768704-9C2FAD28-2378-4202-A7D9-A9B4DA17FDF3Q34011323-B5B28885-F5FF-489A-87A8-8CE0EB6BFA44Q34024833-7997783A-C96E-4C96-A79D-3DE68252A175Q34150135-BD2C1837-DC16-46BC-A23F-4379C2C2ED2BQ34150372-EE0B05D6-A9E8-4412-B0B9-4909233381FFQ34165900-F7A36A97-5DDE-4B9E-8EDD-0C796B24EBE9Q34204713-0BDC812F-4A28-4E0D-8192-5ED0ACD318ECQ34235676-95A95D03-9F48-4E90-B0AF-F7BDAC52A86CQ34339768-76A82944-CF2A-4954-AC89-21B03FC20BD6Q34345955-A3F28013-3EA2-4F7A-9CBF-4CA57F04FADCQ34351020-FA596305-17A0-4CD5-9E2B-9B10076FCEB5Q34491513-FB4FFF88-DB6D-4F7B-B0B8-8C08EA8CEDA7Q34535304-DED7B6D3-C2B8-4C90-80F3-8826C39A071DQ34543535-287DAFB8-9FEE-4FC4-8544-FAA1F8AF0F33Q34554210-5BDD0818-035B-4052-82FE-3758D1853717Q34624995-1755223D-5DC4-414F-8091-8F1AA716811AQ34702380-CBAE651D-E263-4824-8A63-1A5D8B47CFFBQ34707819-D6EDEB7E-0B23-40A3-AAAA-FD5F4408FC7EQ34713362-154A25EB-C45C-47AE-9459-43D8065551E5Q35037024-A00FE0D9-FCC1-4082-A69C-FE445C1E0745Q35097802-6BFF823B-BBB6-458C-9E1B-8C09F313D1FDQ35117410-57B12FC3-8563-4C50-AD47-3122A635E153Q35120602-D223E7A0-A525-4C77-8EBC-7133345EE6F1Q35140622-F1C3FAC4-D2B4-45AB-8BBF-11D46D95FC20Q35164662-5A0E0916-AE2E-4356-8F44-EEA25AE309BFQ35539740-6F549D50-E3F8-469A-9DE9-345F5FEA8C38
P50
name
Héctor H. García
@ast
Héctor H. García
@en
Héctor H. García
@fr
Héctor H. García
@nl
type
label
Héctor H. García
@ast
Héctor H. García
@en
Héctor H. García
@fr
Héctor H. García
@nl
altLabel
Héctor García
@en
prefLabel
Héctor H. García
@ast
Héctor H. García
@en
Héctor H. García
@fr
Héctor H. García
@nl
P1006
P214
P1006
P21
P214
P31
P7859
lccn-no2013109065